Li Zhilin 4
4 · CHINA PHARMA HOLDINGS, INC. · Filed Sep 13, 2021
Insider Transaction Report
Form 4
Li Zhilin
DirectorCEO & Interim CFO10% Owner
Transactions
- Award
Common Stock
2021-09-09$0.67/sh+1,760,000$1,179,200→ 13,810,000 total
Footnotes (1)
- [F1]On September 9, 2021, the reporting person was granted 1,760,000 shares of Issuer's common stock under the Issuer's 2010 Long-Term Incentive Plan, vesting immediately with no restrictions, as partial offset of her accrued but unpaid cash compensation by serving as the Issuer's Chairman of the Board, Chief Executive Officer and interim Chief Financial Officer.